Nicholas W Baxter
CIK 1312326 · President and CEO · last filed 2025-05-16
Nicholas W Baxter is a President and CEO who has filed 30 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for LEXXW, was dated May 16, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
30
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXXW) Delisted | Director | 11,000 | $0.00 | $13 | $0 | 10 | 2025-05-16 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-16 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-30 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-10 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-25 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-13 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-08 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-02 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-30 | — | Sell (S) | −7,573,364 | -$144.7K | |
| 2021-06-09 | Lexaria Bioscience Corp. (LEXXW) Delisted | Other (J) | — | $0 | EDGAR |
| 2021-06-09 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |